Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Quantum Biopharma(QNTM) the Revenue is 0 (--%), Meet estimate;the EBIT is -2.901 M (--%), Miss estimate;the EPS is -2.99 (--%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B--
0.00B--
0.00B--%
EBITMiss expectations
-0.00B--
-0.00B--
-0.00B--%
EPSMiss expectations
-2.9924--
-0.491--
-2.5014--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf